CN108379373A - A kind of Chinese medicine preparation for treating paralysis - Google Patents
A kind of Chinese medicine preparation for treating paralysis Download PDFInfo
- Publication number
- CN108379373A CN108379373A CN201810426955.1A CN201810426955A CN108379373A CN 108379373 A CN108379373 A CN 108379373A CN 201810426955 A CN201810426955 A CN 201810426955A CN 108379373 A CN108379373 A CN 108379373A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- mutual
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 206010033799 Paralysis Diseases 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 241001672694 Citrus reticulata Species 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 16
- 210000004185 liver Anatomy 0.000 abstract description 11
- 206010003549 asthenia Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 7
- 208000007443 Neurasthenia Diseases 0.000 abstract description 6
- 230000006837 decompression Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 4
- 230000000295 complement effect Effects 0.000 abstract description 2
- 230000005764 inhibitory process Effects 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 230000002787 reinforcement Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 244000197580 Poria cocos Species 0.000 description 5
- 235000008599 Poria cocos Nutrition 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 230000006742 locomotor activity Effects 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 241000255789 Bombyx mori Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000501743 Gentiana macrophylla Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000218922 Magnoliophyta Species 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 238000004159 blood analysis Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000036473 myasthenia Effects 0.000 description 2
- -1 n-butene acyl lactone Chemical class 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000715 neuromuscular junction Anatomy 0.000 description 2
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002064 Anaemia macrocytic Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255783 Bombycidae Species 0.000 description 1
- 206010006100 Bradykinesia Diseases 0.000 description 1
- 241000239225 Buthidae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 241000246500 Gentianella aspera Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 206010061533 Myotonia Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037779 Radiculopathy Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241001627955 Tetraodon lineatus Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- VBIXEXWLHSRNKB-UHFFFAOYSA-N ammonium oxalate Chemical compound [NH4+].[NH4+].[O-]C(=O)C([O-])=O VBIXEXWLHSRNKB-UHFFFAOYSA-N 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000006437 macrocytic anemia Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000020469 nerve plexus disease Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 208000013315 neuromuscular junction disease Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000027232 peripheral nervous system disease Diseases 0.000 description 1
- 201000006380 plexopathy Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000002670 vitamin B12 deficiency Diseases 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Insects & Arthropods (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A kind of Chinese medicine preparation for treating paralysis, Chinese medicine material and weight ratio in being formulated are respectively：18 parts of RADIX ANGELICAE SINEINSIS fries 13 parts of rhizome of chuanxiong, 8 parts of Radix Gentianae Marcrophyllae, 7 parts of RADIX SAPOSHINOKOVIAE from Northeast, 5 parts of the full worm of salt, 7 parts of white bombys batryticatus, 16 parts of Rhizoma Atractylodis Macrocephalae, 14 parts of PORIA from Yunnan of China, 12 parts of citrus chachiensis hortorum, 10 parts of fresh ramulus cinnamomi.Raw medicinal material pharmacological property effect selected by the present invention is complementary, evaded the mutual inhibition of compatibility between drug, mutual restraint between two drugs, the mutual-detoxication choosing, make drug mutual reinforcement between, mutually make effect notable, have the function of removing obstruction in channels to relieve pain, for malicious dissipating bind, while having effects that liver protection decompression, prevention neurasthenia.
Description
Technical field
The present invention relates to the field of Chinese medicines, and in particular to and it is a kind of to remove obstruction in channels to relieve pain, treat the Chinese medicine preparation paralysed for malicious dissipating bind,
Treating paralysis to help has effects that good liver protection decompression, prevention neurasthenia.
Background technology
Paralysis,（paralysis）It is the attenuating or forfeiture of voluntary motor function, is the common symptom of nervous system, is god
Caused by, neuromuscular junction or muscle disease.All cortex movement projection areas and upper motor neurons pathway, spinal cord, surrounding god
It is damaged by lesion through, neuromuscular junction or movement muscle itself, can cause to paralyse, the common cause of disease has outside cranium brain
Wound, tumour, inflammation, cerebrovascular disease, denaturation, poisoning and the certain diseases of internal medicine, such as diabetes, hematoporphyria, macrocytic
Anaemia and vitamin B12 deficiency etc..Necessary selective laboratory examination project includes：Blood routine, blood electrolyte, blood
Sugar, urea nitrogen.Limitation of movement caused by certain diseases should be excluded first when judgement paralysis, as Parkinson's disease and other diseases cause
Myotonia or bradykinesia or because limbs pain dare not activity etc..Lesion must be determined according to the symptom and sign of patient first
Positioned at the specified level of neuromuscular system, it just can determine that the cause of disease of myasthenia, myasthenia are distributed to radiculopathy, plexopathy
And the discriminating of peripheral nerve disease and neurogenic and muscle-derived lesion quite has benifit.Being directed to by etiological diagnosis causes arbitrarily to transport
The protopathy of dynamic obstacle is treated.
Invention content
The present invention relates to the field of Chinese medicines, provide it is a kind of remove obstruction in channels to relieve pain, for malicious dissipating bind treatment paralysis Chinese medicine preparation, it is right
Paralysis is treated in help has effects that good liver protection decompression, prevention neurasthenia.
Present invention employs the following technical solutions to achieve the above object：The medicinal material of Chinese medicine preparation selection of the present invention
And parts by weight are respectively：18 parts of RADIX ANGELICAE SINEINSIS, fry 13 parts of rhizome of chuanxiong, 8 parts of Radix Gentianae Marcrophyllae, 7 parts of RADIX SAPOSHINOKOVIAE from Northeast, 5 parts of the full worm of salt, 7 parts of white bombys batryticatus,
16 parts of Rhizoma Atractylodis Macrocephalae, 14 parts of PORIA from Yunnan of China, 12 parts of citrus chachiensis hortorum, 10 parts of fresh ramulus cinnamomi.
In the Chinese medicine material that the present invention selects：
RADIX ANGELICAE SINEINSIS：【Chemical composition】Containing basic lactone, n-butene acyl lactone, ferulic acid, niacin, sucrose and a variety of amino acid, with
And sesquiterpenoids etc..【Meridian distribution of property and flavor】It is warm-natured, it hides sweet, pungent.Return liver, the heart, the spleen channel.【Major function】Replenishing and activating blood is adjusted
Meridian and relieving pain relaxes bowel.For blood deficiency chlorosis, dizziness palpitaition, irregular menstruation, closed dysmenorrhea, asthenia cold abdominalgia, dry constipation of intestines, wind
Arthritis with fixed pain caused by dampness pain, injury from falling down, ulcer sores.
Fry Rhizoma Chuanxiong：Rhizome of chuanxiong, acrid flavour are warm-natured.Return liver, courage, pericardium channel.【Function with cure mainly】Blood-activating and qi-promoting, wind-expelling pain-stopping.With
In pacifying nerve, positive head wind headache, abdominal mass abdominal pain, chest side of body shouting pain, tumbling and swelling, headache, arthralgia pain due to rheumatism.
Radix Gentianae Marcrophyllae：Bark of ash, alias：Gentiana macrophylla, great Ye bark of ash, RADIX GENTIANAE MACROPHYLLAE；Angiospermae, dicotyledon, rough gentian
Section, Latin literary fame：G. macrophylla is Gentianaceae herbaceos perennial, is to control rheumatic arthritis, tuberculosis hectic fever, Huang
One of main ingredients of diseases such as subcutaneous ulcer.
RADIX SAPOSHINOKOVIAE from Northeast：【Original shape classification】Dicotyledonous angiosperm, Umbelliferae, windproof category；Root and all herbal medicine, can wind dispelling town
Bitterly, clearing heat and detoxicating, it controls by diseases such as wind headache, neurasthenia.
The full worm of salt：Full worm is the hirudo leech of full Buthidae animal, has Inflammation Zhijing, removes obstruction in channels to relieve pain, for the work(of malicious dissipating bind
Effect.
White bombys batryticatus：Also known as stiff silkworm, flying worm.Muscardine is infected for the larva of Bombycidae animal bombyx mori and ossified full worm.
The larva of a silkworm with batrytis contains lysine, leucine, 17 kinds of amino acid such as aspartic acid, 28 kinds of members such as magnesium, calcium, zinc containing protein, ammonium oxalate
Element.Meridian distribution of property and flavor：Acrid flavour；It is salty；It is mild-natured.Return liver；Lung；Stomach.Effect：Expelling wind and relieving convulsion；Reducing phlegm and resolving masses；Removing toxic substances relieving sore-throat.It cures mainly：It is frightened
Epilepsy is twitched；Apoplexy deviation of the mouth with numbness and paralysis；Migraine and general headache；Abscess of throat；Scrofula；Mumps；Rubella；Sore.
Rhizoma Atractylodis Macrocephalae：Rhizoma Atractylodis Macrocephalae perennial herb, is used as medicine with rhizome, has multinomial medicinal function.【Meridian distribution of property and flavor】Bitter, sweet, warm.
Returns spleen, stomach.Effect：Strengthening the spleen and replenishing qi, eliminate dampness and have diuretic effect, hidroschesis, tocolysis.For spleen eating less, abdominal distention diarrhea, phlegm retention anti-dazzle nervous, water
It is swollen, spontaneous perspiration, fetal irritability.
PORIA from Yunnan of China：It is one kind in Poria cocos Chinese medicine also known as cloud Siberian cocklebur.Source：For the drying bacterium of On Polyporaceae Poria cocos
Core.The outer skin zone of this sclerotium of Poria cocos（Fuling peel）, Jin Wai skin zones light red color part（Poria cocos）, entertain pine stump among sclerotium
（That is " indian bread hostwood "）White portion（Fushen）Hyoscine.Meridian distribution of property and flavor：It is sweet, light, it puts down.The thoughts of returning home, lung, spleen, kidney channel.Effect：It oozes
Wet Li Shui；Strengthening the spleen and stomach；Antitoxic heart-soothing and sedative.It cures mainly：Difficult urination；Oedema turgor；Phlegm and retained fluid cough is inverse；Vomiting；Spleen eating less；Diarrhea；
Palpitation and restlessness；Insomnia forgetfulness；Seminal emission gonorrhoea.
Citrus chachiensis hortorum：Dried orange peel contains hesperidine about 8.4%, Nobiletin（nobiletin）About 0.15%. separately contains synephrine（To hydroxyl
Forint）0.28%-2.54%.【Attending effectiveness】：Regulating qi-flowing for strengthening spleen, in tune, eliminating dampness, resolving sputum.It cures mainly：The abdominal fullness and distention of the taste stagnation of the circulation of vital energy or
Pain, indigestion.Abdominal distension uncomfortable in chest, indigestion and loss of appetite loose stool in wet turbid resistance.The cough and asthma of phlegm obstructing lung.For chest gastral cavity turgor, food
It is few to vomit and diarrhoea, coughing with a lot of sputum.
Fresh ramulus cinnamomi：For the dry twig of Lauraceae aiphyllium plant Chinese cassia tree.【It cures mainly】Expelling cold and relieving exterior syndrome；Warming meridian；It activates yang
Change gas.Main exterior syndrome due to wind-cold；Numbness and ache of cold dampness；Peripheral coldness；Closed dysmenorrhea；Abdominal mass caking；The obstruction of qi in the chest；Palpitaition；Phlegm and retained fluid；Difficult urination.
For anemofrigid cold, coldness and pain in the epigastrium, blood trembles with fear Amenorrhea, joint pain, phlegm and retained fluid, oedema, palpitaition, run quickly globefish.【Effect】Sweating expelling pathogenic factors from muscles and skin, temperature
Through promoting blood circulation, helps yang transforming qi, eliminating cold to stop pain.Raw medicinal material pharmacological property effect selected by the present invention is complementary, has evaded compatibility between drug
The mutual inhibition, mutual restraint between two drugs, the mutual-detoxication choosing, make drug mutual reinforcement between, mutually make effect notable, have improve immunity, tonifying spleen and kidney, qi and activate blood circulation
The effect of.
The present invention's removes obstruction in channels to relieve pain, for the Chinese medicine preparation for treating paralysis of malicious dissipating bind, and treating paralysis to help has well
Liver protection decompression, prevention neurasthenia the effect of；It is for oral administration, by clinical application, achieve unexpected promising result.
Specific implementation mode
A kind of Chinese medicine preparation for treating paralysis, the Chinese medicine material and parts by weight of selection are respectively：18 parts of RADIX ANGELICAE SINEINSIS fries rhizome of chuanxiong
13 parts, 8 parts of Radix Gentianae Marcrophyllae, 7 parts of RADIX SAPOSHINOKOVIAE from Northeast, 5 parts of the full worm of salt, 7 parts of white bombys batryticatus, 16 parts of Rhizoma Atractylodis Macrocephalae, 14 parts of PORIA from Yunnan of China, citrus chachiensis hortorum 12
Part, 10 parts of fresh ramulus cinnamomi.Preparation method is：
Step 1：By RADIX ANGELICAE SINEINSIS, fry rhizome of chuanxiong, Radix Gentianae Marcrophyllae, RADIX SAPOSHINOKOVIAE from Northeast, the full worm of salt, white bombys batryticatus, Rhizoma Atractylodis Macrocephalae, PORIA from Yunnan of China, citrus chachiensis hortorum,
The Chinese medicine materials such as fresh ramulus cinnamomi are picked, are dried respectively, mix after it is spare；
Step 2：By step（One）Gains smash it through 800 sieves, add ethanolic aqueous system as solvent, and obtained by 2h carries
It takes liquid, water-bath ethanol evaporation to obtain Chinese medicine extract, sterilizes, stand to room temperature and get product.
Clinical drug observation of the present invention：
Accept out-patient totally 39 for medical treatment, age 20-30 Sui 5,31-40 Sui 8,41-50 Sui 20,50 years old or more 6.39
After patient medication, all cure.
Case 1：Week certain, man, building site worker causes the lower part of the body to lose locomotor activity substantially caused by work, the soft inability of foot,
It sleeps bad, loses the appetite, long-term sitting posture causes to have a pain in the back, tinnitus, and pale tongue with white fur is worn out mentally and physically.Laboratory blood examination blood is normal
Rule, blood electrolyte, blood glucose, urea nitrogen.Diagnosis：Neurasthenia, nerve or movement muscle changes, that is, paralyse.Therapy：Powdered medicine ' Tongluosan '
Knot, liver protection protect arteries and veins, separately assist recovery treating.With 14 doses of prescription of the present invention is thrown, take daily 1 dose, sooner or later point 2 decoctions, before meals after
Half an hour takes.With examining later.Symptom is obviously improved, laboratory blood examination blood routine, blood electrolyte, blood glucose, urea nitrogen.Following the service 36
A course for the treatment of, legs and feet can assist walking.It is enjoined, two courses for the treatment of of continual cure consolidate curative effect.Take several doses i.e. more.
Case 2：Lee, man, 40 years old, sleep was bad, loss of appetite, tinnitus, and pale tongue with white fur is paralysed 1 year, and the lower part of the body is basic
Lose locomotor activity.Therapy：Activating collaterals and eliminating stagnation, liver protection protect arteries and veins, separately assist recovery treating.With 14 doses of prescription of the present invention is thrown, 1 is taken daily
Agent, point 2 decoctions sooner or later, half an hour after is taken before meals.36 courses for the treatment of of following the service, legs and feet can assist walking.It is enjoined, continual cure
Two courses for the treatment of consolidate curative effect.Take several doses i.e. more.
Case 3：Fourth, man 65 years old, paralyse 5 years, the lower part of the body loses locomotor activity substantially.Therapy：Activating collaterals and eliminating stagnation, liver protection
Arteries and veins is protected, recovery treating is separately assisted.With 14 doses of prescription of the present invention is thrown, 1 dose is taken daily, sooner or later point 2 decoctions, half an hour after takes before meals
With.48 courses for the treatment of of following the service, legs and feet can assist walking.It is enjoined, two courses for the treatment of of continual cure consolidate curative effect.Take several doses i.e. more.
Case 4：Zhao, female 45 years old, paralyse half a year, and the lower part of the body loses locomotor activity substantially.Therapy：Activating collaterals and eliminating stagnation, liver protection
Arteries and veins is protected, recovery treating is separately assisted.With 14 doses of prescription of the present invention is thrown, 1 dose is taken daily, sooner or later point 2 decoctions, half an hour after takes before meals
With.36 courses for the treatment of of following the service, legs and feet can assist walking.It is enjoined, two courses for the treatment of of continual cure consolidate curative effect.Take several doses i.e. more.
The results show:A kind of pure Chinese medicine Zhitan preparation of the present invention, it is nonirritant to personal body, have bright
Aobvious strong bone of allaying one's hunger increases the effect of blood vessel elasticity.
Claims (2)
1. a kind of Chinese medicine preparation for treating paralysis, which is characterized in that Chinese medicine material and parts by weight in formula are respectively：RADIX ANGELICAE SINEINSIS
18 parts, fry 13 parts of rhizome of chuanxiong, 8 parts of Radix Gentianae Marcrophyllae, 7 parts of RADIX SAPOSHINOKOVIAE from Northeast, 5 parts of the full worm of salt, 7 parts of white bombys batryticatus, 16 parts of Rhizoma Atractylodis Macrocephalae, PORIA from Yunnan of China 14
Part, 12 parts of citrus chachiensis hortorum, 10 parts of fresh ramulus cinnamomi.
2. a kind of preparation method of Chinese medicine preparation for treating paralysis described in accordance with the claim 1, which is characterized in that including following
Step：
Step 1：RADIX ANGELICAE SINEINSIS is taken by part, fries rhizome of chuanxiong, Radix Gentianae Marcrophyllae, RADIX SAPOSHINOKOVIAE from Northeast, the full worm of salt, white bombys batryticatus, Rhizoma Atractylodis Macrocephalae, PORIA from Yunnan of China, wide old
Skin, fresh ramulus cinnamomi Chinese medicine material, picked, dried respectively, mix after it is spare；
Step 2：Step 1 gains are smashed it through into 800 sieves, add ethanolic aqueous system as solvent, by the obtained extraction of 2h
Liquid, water-bath ethanol evaporation obtain Chinese medicine extract, and sterilizing stands to room temperature and gets product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810426955.1A CN108379373A (en) | 2018-05-07 | 2018-05-07 | A kind of Chinese medicine preparation for treating paralysis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810426955.1A CN108379373A (en) | 2018-05-07 | 2018-05-07 | A kind of Chinese medicine preparation for treating paralysis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108379373A true CN108379373A (en) | 2018-08-10 |
Family
ID=63070669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810426955.1A Pending CN108379373A (en) | 2018-05-07 | 2018-05-07 | A kind of Chinese medicine preparation for treating paralysis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108379373A (en) |
-
2018
- 2018-05-07 CN CN201810426955.1A patent/CN108379373A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105412893A (en) | Jingutong spray and making method thereof | |
| CN102772778B (en) | Traditional Chinese medicine composition for treating summer heat-dampness | |
| CN105412899A (en) | Traditional Chinese medicine preparation for relieving erythromelalgia and preparation method thereof | |
| CN103611097B (en) | One treats innominate toxic swelling Chinese medicine | |
| CN103830425B (en) | Traditional Chinese medicine for treating blood deficiency type skin itch | |
| CN105456957A (en) | Traditional Chinese medicine composition for treating bromhidrosis | |
| CN108379373A (en) | A kind of Chinese medicine preparation for treating paralysis | |
| CN104548013A (en) | Traditional Chinese medicine for treating facial paralysis and preparation method of traditional Chinese medicine | |
| CN104107373A (en) | Traditional Chinese medicine for treating beriberi, foot odor and foot sweating | |
| CN109172708A (en) | A kind of dispelling wind and removing obstruction in the meridians liquid medicine and production method and eating method | |
| CN102861171B (en) | Traditional Chinese medicine composite for treating bovine stomatitis and preparation method thereof | |
| CN106310172A (en) | Ointment medicine for treating painful diseases and preparing method and use thereof | |
| CN106729443A (en) | A kind of Chinese medicine composition for swelling and pain relieving and preparation method thereof | |
| CN106421514A (en) | Traditional Chinese medicine for treating arthralgia | |
| CN104825883A (en) | Traditional Chinese medicine prescription for treating rhinitis | |
| CN103638506B (en) | A kind of Chinese medicine for the treatment of arthromyodynia | |
| CN106619852A (en) | Traditional Chinese medicine lavipeditum life cultivation and health preservation prescription with effects of warming channels and dispersing cold, and dredging grain of skin and texture of the subcutaneous flesh | |
| CN103006963A (en) | Medicine for treating animal traumatic infection diseases | |
| CN104524535A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition | |
| CN104161844A (en) | Traditional Chinese medicine prescription for treating livestock and poultry flu | |
| CN103610815B (en) | A kind of Chinese medicine for the treatment of cellulitis | |
| CN108310237A (en) | Zhitan Chinese medicine is drunk | |
| CN103202994B (en) | A kind of charcoal fire medication technology for treating treating rheumatic ostealgia | |
| CN109745532A (en) | A kind of particle side for treating wind-cold type crythema multiforme | |
| CN108420985A (en) | A kind of pure Chinese medicine Zhitan preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180810 |
|
| RJ01 | Rejection of invention patent application after publication |